A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article…
A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article…
Findings reported by University of Hawai’i Cancer Center researchers could eventually improve survival for patients with an aggressive cancer that attacks the lining of the chest wallAspirin may…
Findings reported by University of Hawai’i Cancer Center researchers could eventually improve survival for patients with an aggressive cancer that attacks the lining of the chest wallAspirin may…
Findings reported by University of Hawai’i Cancer Center researchers could eventually improve survival for patients with an aggressive cancer that attacks the lining of the chest wallAspirin may…
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global ban, states a commentary in CMAJ (Canadian Medical…
To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global ban, states a commentary in CMAJ (Canadian Medical…
Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients’ own immune cells successfully traveled to tumors they were…
PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…
PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…
Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients’ own immune cells successfully traveled to tumors they were…
The use of asbestos continues to increase in Asia despite clear health hazards. A recent Respirology review notes that with approximately 4.